|
N/A
|
268201000041C
|
$500,000
|
$500,000
|
N/A
|
BATTELLE MEMORIAL INSTITU
|
|
N/A
|
275200900087U
|
$110,000
|
$110,000
|
N/A
|
COURTESY ASSOCIATES, LLC:
|
|
N/A
|
271200900034C
|
$50,000
|
$50,000
|
N/A
|
EMMES CORP
|
|
N/A
|
276201000332U
|
$87,374
|
$87,374
|
N/A
|
FORESIGHT SCIENCE & TECHN
|
|
N/A
|
ZIFBC000001-06
|
$113,389,553
|
$113,389,553
|
N/A
|
National Cancer Institute
|
|
N/A
|
ZIACO020003-04
|
$4,503
|
$4,503
|
Lowy, Douglas
|
National Cancer Institute
|
|
N/A
|
ZIACO020007-04
|
$14,053,798
|
$14,053,798
|
Lowy, Douglas
|
National Cancer Institute
|
|
N/A
|
ZIHCO020005-04
|
$27,200,000
|
$27,200,000
|
Lowy, Douglas
|
National Cancer Institute
|
|
N/A
|
ZIICO020002-04
|
$4,777,709
|
$4,777,709
|
Lowy, Douglas
|
National Cancer Institute
|
|
N/A
|
ZIKCO020001-04
|
$5,807,873
|
$5,807,873
|
Lowy, Douglas
|
National Cancer Institute
|
|
N/A
|
BldFacilities13
|
$7,904,000
|
$7,904,000
|
N/A
|
National Institutes of Health
|
|
N/A
|
NTR12004001
|
$75,000
|
$75,000
|
N/A
|
NCATS-NATIONAL CENTER FOR
|
|
N/A
|
NTR13003001
|
$468,000
|
$468,000
|
N/A
|
NCATS-NATIONAL CENTER FOR
|
|
N/A
|
NCT12003001
|
$800,000
|
$800,000
|
N/A
|
NIH-NATIONAL INSTITUTES O
|
|
N/A
|
276201200047U
|
$86,058
|
$86,058
|
N/A
|
OCTO CONSULTING GROUP, IN
|
|
N/A
|
NOD13001001
|
$633,050
|
$633,050
|
N/A
|
OD-OFFICE OF THE DIRECTOR
|
|
N/A
|
268201000022C
|
$100,000
|
$100,000
|
N/A
|
RESEARCH TRIANGLE INSTITU
|
|
N/A
|
PUR2884480-1
|
$3,068
|
$3,068
|
N/A
|
STERLING COMPUTERS
|
|
"BCR/ABL-PI-3k-ROS pathway induce genomic instability ...."
|
5R01CA134458-04
|
$289,474
|
$289,474
|
SKORSKI, TOMASZ
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
"Comparative gene resequencing in mouse cancer models"
|
5K08CA160658-03
|
$180,360
|
$180,360
|
McFadden, David
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
5R00CA134743-04
|
$245,188
|
$245,188
|
Feng, Hui
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
"Repair Co-ordination of Radiation-Induced Clustered Damage In Mammalian Genomes"
|
5R01CA158910-02
|
$298,427
|
$298,427
|
Mitra, Sankar
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
'Exvading' Invasive Pediatric Brain Tumors
|
5R01CA153229-04
|
$231,106
|
$231,106
|
Bellamkonda, Ravi
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
(PQ6) Molecular Mechanisms of Dormancy in MYC-Driven Medulloblastoma
|
1R21CA180063-01
|
$254,475
|
$254,475
|
Pei, Yanxin
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise
|
1R01CA179963-01
|
$559,672
|
$559,672
|
Bryan, Angela
|
UNIVERSITY OF COLORADO
|
|
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer
|
1R01CA180277-01
|
$275,552
|
$275,552
|
Li, Xin
|
NEW YORK UNIVERSITY
|
|
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
|
1R01CA180033-01
|
$295,065
|
$295,065
|
MISKIMINS, W
|
SANFORD RESEARCH/USD
|
|
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
|
1R01CA180070-01
|
$377,488
|
$377,488
|
HEBER-KATZ, ELLEN S.
|
WISTAR INSTITUTE
|
|
(PQA2) Reversing Carcinogenic Effect of Obesity on Basal-like Breast Cancer
|
1R21CA180134-01
|
$192,411
|
$192,411
|
HAYES, LIZA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'
|
1R01CA179992-01
|
$735,574
|
$735,574
|
JONES, LEE
|
DUKE UNIVERSITY
|
|
(PQB5) Does the timing of Pten and Rb1 mutation affect prostate cancer phenotypes
|
1R21CA179907-01
|
$221,589
|
$221,589
|
GOODRICH, DAVID
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
(PQB6) Accurate Comparative Genome-wide Analysis of Primary Tumors and Metastases
|
1R21CA180016-01
|
$206,190
|
$206,190
|
Wotton, David
|
UNIVERSITY OF VIRGINIA
|
|
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
|
1R21CA179981-01
|
$197,055
|
$197,055
|
Henry, Michael
|
UNIVERSITY OF IOWA
|
|
(PQC4) Fate of cells disseminating from human breast cancer xenografts
|
1R01CA180039-01
|
$325,775
|
$325,775
|
WERB, ZENA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQC5) Detecting small clusters of tumor cells with a PTPmu probe
|
1R01CA179956-01
|
$645,638
|
$645,638
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
(PQD-1) NF-kB activation and enzalutamide therapy in metastatic castration resist
|
1R21CA179970-01
|
$200,970
|
$200,970
|
GAO, ALLEN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
|
1R01CA180037-01
|
$325,948
|
$325,948
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition
|
1R01CA180150-01
|
$558,328
|
$558,328
|
Petroski, Matthew
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
(PQD3) Genetic Basis of Breast Cancer Resistance in BRCA1+ Carrier
|
1R21CA180008-01
|
$174,788
|
$174,788
|
WANG, SAN MING
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
(PQD4) SIGNS OF INFLAMMATORY BREAST CANCER ARE CAUSED BY STROMAL FIELD EFFECTS
|
1R01CA180061-01
|
$460,025
|
$460,025
|
Woodward, Wendy
|
UT MD ANDERSON CANCER CTR
|
|
(PQD5) Development of in Vitro Vascularized Microtumors for Drug Screening
|
1R01CA180122-01
|
$312,400
|
$312,400
|
HUGHES, CHRISTOPHER
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
1 BUSINESS PROCESS IMPROVEMENT - ORGANIZATIONAL ASSESSMENT SUPPORT; 2 NCI SUPPORT
|
N01CA120074
|
$40,000
|
$40,000
|
UNKNOWN, UNKNOWN
|
NATIONAL ACADEMY OF SCIENCES:1108676
|
|
1) Computing Services for DCP; 2) Prostate, Lung, Colorectal, and Ovarian (PLCO)
|
N01CA130008
|
$4,401,871
|
$4,401,871
|
UNKNOWN, UNKNOWN
|
INFORMATION MANAGEMENT SERVICES, INC.
|
|
15th IMS New Researchers Conference
|
1R13EB017582-01
|
$5,000
|
$5,000
|
Singh, Aarti
|
CARNEGIE-MELLON UNIVERSITY
|
|
18F-Fluorocholine to distinguish necrosis from recurrence in brain metastases
|
1R21CA170289-01A1
|
$366,860
|
$366,860
|
Beal, Kathryn
|
SLOAN-KETTERING INST CAN RES
|
|
18th Annual Meeting of the PanAmerican Society of Pigment Cell Research
|
1R13AR065373-01
|
$3,000
|
$3,000
|
SETALURI, VIJAYASARADHI
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
2-Amino-9H-pyrido[2,3-b]indole: a potential colorectal carcinogen formed in tobac
|
7R01CA134700-05
|
$127,525
|
$127,525
|
Turesky, Robert
|
UNIVERSITY OF MINNESOTA
|
|
2-Amino-9H-pyrido[2,3-b]indole: a potential colorectal carcinogen formed in tobac
|
5R01CA134700-04
|
$135,571
|
$135,571
|
Turesky, Robert
|
WADSWORTH CENTER
|
|
2013 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA177075-01
|
$15,000
|
$15,000
|
LUSCINSKAS, FRANCIS
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
2013 California Breast Cancer Research Symposium From Research to Action a Decade
|
1R13ES022921-01
|
$4,000
|
$4,000
|
Kavanaugh-Lynch, Marion
|
UNIVERSITY OF CALIFORNIA SYS OFFICE/PRES
|
Total relevant funding to Cancer for this search: $2,747,190,757
|